Black Rock Inc. Biomarin Pharmaceutical Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Black Rock Inc. holds 22,738,349 shares of BMRN stock, worth $1.6 Billion. This represents 0.04% of its overall portfolio holdings.

Number of Shares

22,738,349

Previous 14,478,790 57.05%

Holding current value

$1.6 Billion

Previous $1.26 Billion 48.04%

% of portfolio

0.04%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $615 Million - $762 Million	8,259,559 Added 57.05%	22,738,349 $1.87 Billion
Q1 2024 May 10, 2024	SELL	$83.81 - $99.0 $17 Million - $20.1 Million	-202,854 Reduced 1.38%	14,478,790 $1.26 Billion
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $5.68 Million - $7.33 Million	74,457 Added 0.51%	14,681,644 $1.42 Billion
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $50.3 Million - $55.9 Million	591,722 Added 4.22%	14,607,187 $1.29 Billion
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $54 Million - $62.5 Million	-623,111 Reduced 4.26%	14,015,465 $1.21 Billion
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $8.63 Million - $11.5 Million	98,385 Added 0.68%	14,638,576 $1.42 Billion
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $20.4 Million - $27.4 Million	252,332 Added 1.77%	14,540,191 $1.5 Billion
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $10.6 Million - $12.5 Million	-129,242 Reduced 0.9%	14,287,859 $1.21 Billion
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $32.8 Million - $39.9 Million	459,041 Added 3.29%	14,417,101 $1.19 Billion
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $4.22 Million - $5.27 Million	56,879 Added 0.41%	13,958,060 $1.08 Billion
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $102 Million - $130 Million	-1,419,618 Reduced 9.27%	13,901,181 $1.23 Billion
Q3 2021 Nov 09, 2021	BUY	$74.77 - $85.47 $181 Million - $207 Million	2,425,231 Added 18.81%	15,320,799 $1.18 Billion
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $974 Million - $1.09 Billion	12,895,568 New	12,895,568 $1.08 Billion

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account